Novel therapy for acute migraine shows promise in phase 3 clinical trial

A drug belonging to a new generation of acute migraine headache treatments was found to eliminate pain and reduce bothersome symptoms for people with migraine in a large-scale trial. The drug, rimegepant, is awaiting US Food and Drug Administration approval and may offer advantages over currently available migraine medications.